作为神经母细胞瘤分化的关键调节剂和有前途的治疗点的PLK4
Xiangdong Tian1, Yuren Xia1, Wenchen Gong1
1Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Tianjin, China.
PLK4调节神经母细胞瘤的分化,这是预后的一个关键因素. 抑制PLK4促进神经元成熟,并可能克服对13- cis RA治疗的耐药性.
科学领域:
- 癌症学
- 分子生物学
- 细胞生物学
背景情况:
- 神经母细胞瘤 (NB) 的分化对于患者的预后和治疗结果至关重要.
- 目前用于NB的分化疗法有效性有限.
- NB分化的分子驱动因素尚未完全阐明,PLK4的作用尚不清楚.
研究的目的:
- 研究PLK4在神经母细胞瘤分化中的作用.
- 确定PLK4介导的分化背后的分子机制.
- 评估PLK4作为神经母细胞瘤的治疗点.
主要方法:
- 通过调节其体外和体内表达来研究PLK4的作用.
- 采用西式涂抹,共免疫沉和免疫光.
- 使用小鼠神经母细胞瘤模型和药理学PLK4抑制.
主要成果:
- 减少PLK4可促进神经母细胞神经元的分化,并使细胞对13- cis RA敏感.
- 通过PI3K/Akt和cyclin D1调节差异化的新型PLK4-CXCR4信号轴.
- 一种选择性PLK4抑制剂 (CFI-400945) 显示双重活性:促进分化和抑制增殖.
结论:
- 作为神经母细胞瘤分化的关键调节剂.
- PLK4 是一个有前途的治疗点,可以提高分化疗法的疗效,并克服对13- cis RA的耐药性.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
相关概念视频
Negative Regulator Molecules
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
